Is Viridian Therapeutics, Inc. (VRDN) a Buy, Sell, or Hold?
NASDAQ : VRDN
Viridian Therapeutics, Inc. — Competitors
$18.92 USD
-$0.98 (-4.92%)
- Volume
- 1.09M
- Average Volume
- 2.56M
- Market Capitalization
- $1.7B
- P/E Ratio
- -5.44
- Dividend Yield
- 0.00%
- Price Target
- $38.50
- Year High
- $34.29
- Year Low
- $13.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.15
VRDN vs. The Competition
| Properties | VRDN | CLDX | COGT | EWTX |
|---|---|---|---|---|
| Market Cap | $1.7B | $2.53B | $6.65B | $4.13B |
| Shares Outstanding | $90M | $66.54M | $170.87M | $107.59M |
| P/E Ratio | -5.44 | -8.91 | -12.64 | -23.15 |
| EPS | -3.53 | -4.26 | -5.26 | -1.64 |
| Day Low | 18.89 | 37.15 | 38.755 | 38.21 |
| Day High | 19.775 | 38.65 | 41.305 | 41.11 |
| Year Low | 13.18 | 19.72 | 10.38 | 12.3 |
| Year High | 34.29 | 40.3 | 43.73 | 48.4 |
| Average Price 50 | 17.954 | 34.1118 | 36.5047 | 38.2578 |
| Average Price 200 | 23.99065 | 29.64975 | 34.7368 | 29.71618 |
| Volume | 1.09M | 875.74K | 1.55M | 1.15M |
| Average Volume | - | - | - | - |